A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: implications for antiangiogenic therapy

Harrison's Principles of Internal Medicine.

1988 • 11,687 citations

Angiogenesis in cancer and other diseases

2000 • 8,734 citations

Isolation of Putative Progenitor Endothelial Cells for Angiogenesis

1997 • 8,673 citations

Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis

1996 • 6,878 citations

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

1995 • 2,650 citations

Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization

1999 • 2,425 citations

Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy

2001 • 2,069 citations

Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

2001 • 1,874 citations

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

1999 • 1,852 citations

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.

2000 • 1,536 citations

Origins of circulating endothelial cells and endothelial outgrowth from blood

2000 • 1,529 citations

MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis

2000 • 1,306 citations

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

2000 • 1,159 citations

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

2002 • 1,066 citations

SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.

1999 • 1,044 citations

Tumor angiogenesis: past, present and the near future

2000 • 973 citations

Vascular Endothelial Growth Factor and Angiopoietin-1 Stimulate Postnatal Hematopoiesis by Recruitment of Vasculogenic and Hematopoietic Stem Cells

2001 • 692 citations

Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?

2002 • 685 citations

Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment

2002 • 638 citations

Disruption of Angiogenesis by PEX, a Noncatalytic Metalloproteinase Fragment with Integrin Binding Activity

1998 • 618 citations

In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy

2001 • 603 citations

Endothelial Progenitor Cell Vascular Endothelial Growth Factor Gene Transfer for Vascular Regeneration

2002 • 587 citations

Physiologically Based Pharmacokinetic Modeling: Principles and Applications

1983 • 560 citations

Endothelial Cells of Hematopoietic Origin Make a Significant Contribution to Adult Blood Vessel Formation

2000 • 524 citations

A Role for Hematopoietic Stem Cells in Promoting Angiogenesis

2000 • 512 citations

SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.

2000 • 501 citations

During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium

1996 • 449 citations

Myocardial gene therapy.

2002 • 302 citations

Angiogenesis and Metastasis

2002 • 294 citations

Adhesion events in angiogenesis

2001 • 286 citations

Determination of bone marrow–derived endothelial progenitor cell significance in angiogenic growth factor–induced neovascularization in vivo

2002 • 272 citations

Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice.

2001 • 199 citations

Human Endothelial Progenitor Cell-Seeded Hybrid Graft: Proliferative and Antithrombogenic Potentialsin Vitroand Fabrication Processing

2003 • 196 citations

Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice

2002 • 188 citations

Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-γ and migration of endothelial cells expressing Flt 1

1998 • 172 citations

Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma.

2001 • 163 citations

Contribution of marrow-derived progenitors to vascular and cardiac regeneration

2002 • 161 citations

Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue

2003 • 154 citations

Tissue Perfusion Inhomogeneity During Early Tumor Growth in Rats<xref ref-type="fn" rid="fn2">2</xref>

1979 • 152 citations

Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization

2003 • 136 citations

Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors.

2003 • 124 citations

Local imbalance of proangiogenic and antiangiogenic factors: a potential mechanism of focal necrosis and dormancy in tumors.

2000 • 101 citations

Ecstasy danger hits the headlines

2002 • 101 citations

Relationship between selectin-mediated rolling of hematopoietic stem and progenitor cells and progression in hematopoietic development

2000 • 90 citations

Diffusion model of tumor vascularization and growth

1977 • 66 citations

Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell-induced angiogenesis

2001 • 64 citations

Diffusion model of tumor vascularization and growth

1977 • 21 citations